The Report concluded that there is scope for improvements in a number of areas, including:
- transparency of the process
- communications with, and the availability of, information to patients
- tracking the progression of medicines through the process
The Minister for Health fully supports any recommendations contained in the Report that improve the process, provide easier access, and support value for money.
Speaking on the publication of the report, Derick Mitchell IPPOSI CEO stated that ‘although long overdue, the publication of this report is an important step in the reform of our medicines access process in Ireland. The report findings are sensible and practical, and need consideration in the Irish context. The fact that many other countries, including our near neighbours in Scotland, have many of these reforms already in place is a cause for concern for many patient groups’, he said.
IPPOSI looks forward to engaging with the new working group in 2023 as part of its consultation with patient groups.
Lynch Syndrome Ireland 